PlumX Metrics
Embed PlumX Metrics

Use of cystic fibrosis inhaled medication before and after elexacaftor/tezacaftor/ivacaftor initiation

Journal of Cystic Fibrosis, ISSN: 1569-1993, Vol: 23, Issue: 1, Page: 29-31
2024
  • 5
    Citations
  • 0
    Usage
  • 10
    Captures
  • 1
    Mentions
  • 31
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    5
    • Citation Indexes
      5
  • Captures
    10
  • Mentions
    1
    • News Mentions
      1
      • 1
  • Social Media
    31
    • Shares, Likes & Comments
      31
      • Facebook
        31

Most Recent News

Reports Summarize Cystic Fibrosis Findings from Aristotle University of Thessaloniki (Use of Cystic Fibrosis Inhaled Medication Before and After Elexacaf Tor/tezacaf Tor/ivacaf Tor Initiation)

2024 JUN 06 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- New research on Lung Diseases and Conditions - Cystic

Article Description

Elexacator/tezacaftor/ivacaftor (ETI) has improved cystic fibrosis (CF) outcomes. A reduction in use of maintenance medication after its initiation has been reported. Seventy-one adult people with CF (PwCF) who are followed in three CF centers and completed one year of treatment with ETI were included in this study. Their use of inhaled dornase-α, colistin, tobramycin, aztreonam and levofloxacin during this period was compared with the corresponding use during one year without ETI, using the Medication Possession Ratio (MPR). MPR was significantly decreased after ETI initiation for dornase-α (67±35% vs 48±40%, p <0.001) and for all four inhaled antibiotics together (62±33% vs 41±37%, p <0.001). The findings of this multi-center, retrospective, study suggest that the initiation of ETI significantly leads to decrease in use of standard inhaled medication in PwCF. The significance of this finding in the course of the disease is yet to be investigated by larger prospective clinical trials.

Bibliographic Details

Manika, Katerina; Diamantea, Filia; Tsakona, Anna; Kakolyris, Alexandros; Sopiadou, Athina; Kotoulas, Serafeim-Chrysovalantis; Sionidou, Maria; Kirvasili, Sirmo-Stiliani; Hadji-Mitrova, Marija; Papadaki, Eleni; Chrysochoou, Elisavet-Anna; Hatziagorou, Elpis

Elsevier BV

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know